Case Control Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Sep 15, 2022; 14(9): 1689-1698
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1689
Table 2 Difference in Helicobacter pylori infection among controls and cases with esophageal precancerous lesions
GroupH. pylori infection
P valuea
Negative
Positive
Positive rate
Controls1425829.0%
EPL cases (upper and mid thoracic esophagus)1003324.8%0.384
EPL cases (lower thoracic esophagus)531420.9%